Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Opinion in Lipidology|September 5, 2015
The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significanceMiriam Lee-Rueckert, Petri T Kovanen
Current Opinion in Lipidology|September 2, 2011
Extracellular modifications of HDL in vivo and the emerging concept of proteolytic inactivation of preβ-HDLMiriam Lee-Rueckert, Petri T Kovanen
Biochimica Et Biophysica Acta|March 13, 2016
HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to human diseaseMiriam Lee-Rueckert, Joan Carles Escola-Gil, Petri T Kovanen
Current Medicinal Chemistry|August 24, 2019
Molecular Insights into the Mechanisms Underlying the Cholesterol- Lowering Effects of PhytosterolsLídia Cedó, Marta Farràs, Miriam Lee-Rueckert, et al.
Frontiers in Cardiovascular Medicine|March 3, 2022
Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative ViewMiriam Lee-Rueckert, Jani Lappalainen, Petri T Kovanen, et al.
Journal of Lipid Research|November 10, 2007
Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymaseMiriam Lee-Rueckert, Riikka Vikstedt, Jari Metso, et al.
Atherosclerosis|April 3, 2016
Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activationRafaela F da Silva, Jani Lappalainen, Miriam Lee-Rueckert, et al.
Progress in Lipid Research|April 24, 2013
The role of the gut in reverse cholesterol transport--focus on the enterocyteMiriam Lee-Rueckert, Francisco Blanco-Vaca, Petri T Kovanen, et al.
Pageof 4